Workflow
Translational Development Acquisition Corp.(TDACU)
icon
Search documents
Translational Development Acquisition Corp.(TDACU) - 2025 Q3 - Quarterly Report
2025-11-14 21:08
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2025 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-42451 TRANSLATIONAL DEVELOPMENT ACQUISITION CORP. (Exact name of registrant as specified in its charter) ...
Translational Development Acquisition Corp.(TDACU) - 2025 Q2 - Quarterly Report
2025-08-14 20:08
Part I. Financial Information This section presents the Company's unaudited interim financial statements, management's analysis, market risk, and internal controls [Item 1. Interim Financial Statements](index=3&type=section&id=Item%201%2E%20Interim%20Financial%20Statements) This section presents the unaudited condensed financial statements, including balance sheets, statements of operations, changes in shareholders' deficit, cash flows, and notes [Condensed Balance Sheets](index=3&type=section&id=Condensed%20Balance%20Sheets) This section presents the Company's financial position, detailing assets, liabilities, and shareholders' deficit at period-end | Metric | June 30, 2025 (Unaudited) | December 31, 2024 | | :-------------------------------- | :-------------------------- | :------------------ | | Cash | $35,255 | $438,174 | | Prepaid expenses | $120,822 | $212,059 | | Total Current Assets | $156,077 | $650,233 | | Marketable securities held in Trust Account | $178,025,297 | $174,350,346 | | TOTAL ASSETS | $178,181,374 | $175,000,579 | | Accounts payable and accrued expenses | $162,920 | $16,189 | | Due to Sponsor | $46,762 | $2,000 | | Accrued offering costs | $75,000 | $192,114 | | Total Current Liabilities | $284,682 | $210,303 | | Deferred underwriting fee | $6,037,500 | $6,037,500 | | TOTAL LIABILITIES | $6,322,182 | $6,247,803 | | Class A ordinary shares subject to possible redemption | $178,025,297 | $174,350,346 | | Total Shareholders' Deficit | $(6,166,105) | $(5,597,570) | [Condensed Statements of Operations](index=4&type=section&id=Condensed%20Statements%20of%20Operations) This section presents the Company's financial performance, detailing revenues, expenses, and net income (loss) for the reported periods | Metric | For the Three Months Ended June 30, 2025 | For the Three Months Ended June 30, 2024 | For the Six Months Ended June 30, 2025 | For the Six Months Ended June 30, 2024 | | :------------------------------------------------- | :--------------------------------------- | :--------------------------------------- | :------------------------------------- | :------------------------------------- | | General and administrative costs | $221,127 | $1,685 | $568,535 | $1,685 | | Loss from operations | $(221,127) | $(1,685) | $(568,535) | $(1,685) | | Dividends earned on marketable securities | $1,844,469 | $0 | $3,674,951 | $0 | | Net income (loss) | $1,623,342 | $(1,685) | $3,106,416 | $(1,685) | | Basic and diluted net income per redeemable Class A ordinary share | $0.07 | $0.00 | $0.14 | $0.00 | | Basic and diluted net income (loss) per non-redeemable Class B ordinary share | $0.07 | $(0.00) | $0.14 | $(0.00) | [Condensed Statements of Changes in Shareholders' Deficit](index=5&type=section&id=Condensed%20Statements%20of%20Changes%20in%20Shareholders%27%20Deficit) This section details the changes in the Company's shareholders' deficit over specific periods, reflecting net income, accretion, and other equity adjustments | Period | Balance — December 31, 2024 | Accretion for Class A ordinary shares to redemption amount | Net income | Balance – June 30, 2025 | | :-------------------------------- | :-------------------------- | :------------------------------------------------------- | :--------- | :---------------------- | | Shareholders' Deficit | $(5,597,570) | $(3,674,951) | $3,106,416 | $(6,166,105) | [Condensed Statements of Cash Flows](index=6&type=section&id=Condensed%20Statements%20of%20Cash%20Flows) This section summarizes the Company's cash inflows and outflows from operating, investing, and financing activities over specific periods | Metric | For the Six Months Ended June 30, 2025 | For the Six Months Ended June 30, 2024 | | :------------------------------------------------- | :------------------------------------- | :------------------------------------- | | Net income (loss) | $3,106,416 | $(1,685) | | Dividends and unrealized gain on marketable securities held in Trust Account | $(3,674,951) | $0 | | Net cash used in operating activities | $(402,919) | $0 | | Net cash provided by financing activities | $0 | $70,000 | | Net Change in Cash | $(402,919) | $70,000 | | Cash – End of period | $35,255 | $72,021 | [Notes to Condensed Financial Statements](index=7&type=section&id=Notes%20to%20Condensed%20Financial%20Statements) This section provides detailed explanatory notes to the condensed financial statements, covering significant accounting policies, financial instruments, and other disclosures - The Company was incorporated on April 19, 2022, as a blank check company (SPAC) for the purpose of effecting a business combination[23](index=23&type=chunk) - The Initial Public Offering (IPO) of **17,250,000 units at $10.00 per unit** was consummated on December 24, 2024, generating gross proceeds of **$172,500,000**[25](index=25&type=chunk) - An amount of **$174,225,000** from the IPO proceeds and private placement warrants was placed in a Trust Account on December 24, 2024, and invested in U.S. government securities or money market funds[29](index=29&type=chunk) - Public shareholders have the opportunity to redeem their Public Shares for a pro rata portion of the Trust Account upon completion of a Business Combination[30](index=30&type=chunk)[31](index=31&type=chunk) - The Company must complete a Business Combination by **June 24, 2026** (18 months from IPO closing), or it will cease operations and liquidate[37](index=37&type=chunk) - Management has determined that liquidity issues and the mandatory liquidation deadline raise substantial doubt about the Company's ability to continue as a going concern if a Business Combination is not completed by **June 20, 2026**[46](index=46&type=chunk)[47](index=47&type=chunk)[49](index=49&type=chunk) - The Company is an "emerging growth company" and has elected not to opt out of the extended transition period for complying with new or revised financial accounting standards[55](index=55&type=chunk)[56](index=56&type=chunk) - Marketable securities held in the Trust Account, primarily U.S. Treasury securities in money market funds, are classified as trading securities and measured at fair value using Level 1 inputs[62](index=62&type=chunk)[64](index=64&type=chunk) - Class A ordinary shares subject to possible redemption are classified as temporary equity, with changes in redemption value recognized immediately[79](index=79&type=chunk) - The Sponsor holds **4,657,500 Class B ordinary shares** (Founder Shares), which automatically convert to Class A ordinary shares upon the initial Business Combination[84](index=84&type=chunk) - The Company pays its Sponsor a monthly fee of **$10,000** for administrative and support services, incurring **$30,000** and **$60,000** for the three and six months ended June 30, 2025, respectively[90](index=90&type=chunk) - **7,075,000 Private Placement Warrants** were purchased by the Sponsor and BTIG at **$1.00 per warrant**, generating **$7,075,000**, with proceeds added to the Trust Account[92](index=92&type=chunk) - A deferred underwriting fee of **$6,037,500** is payable to the underwriters upon the completion of a Business Combination[98](index=98&type=chunk) - As of June 30, 2025, there were **15,700,000 warrants outstanding** (8,625,000 Public Warrants and 7,075,000 Private Placement Warrants)[106](index=106&type=chunk) - The Company may redeem outstanding warrants at **$0.01 per warrant** if the Class A ordinary share price equals or exceeds **$18.00** for 20 trading days within a 30-day period, subject to an effective registration statement[108](index=108&type=chunk)[111](index=111&type=chunk) - The Chief Financial Officer is identified as the Chief Operating Decision Maker (CODM), and management has determined there is only one reportable segment[116](index=116&type=chunk) - On August 8, 2025, the Company entered into a non-interest bearing promissory note with the Sponsor for up to **$2,000,000**, due upon the closing of a Business Combination[122](index=122&type=chunk) [Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations](index=30&type=section&id=Item%202%2E%20Management%27s%20Discussion%20and%20Analysis%20of%20Financial%20Condition%20and%2
Translational Development Acquisition Corp.(TDACU) - 2025 Q1 - Quarterly Report
2025-05-15 21:05
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarter ended March 31, 2025 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-42451 TRANSLATIONAL DEVELOPMENT ACQUISITION CORP. (Exact name of registrant as specified in its charter) Cayman Island ...
Translational Development Acquisition Corp.(TDACU) - 2024 Q4 - Annual Report
2025-03-31 20:05
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2024 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 001-42451 | TRANSLATIONAL DEVELOPMENT ACQUISITION CORP. | | | | | --- | --- | --- | --- | | (Exact name of registrant a ...